Institutional investors control 0.45% of the outstanding shares in NVGN. This represents a greater percentage of ownership than at almost any other company in the Biotechnology industry. Additionally, during the quarter ended December 2013, these large investors purchased a net $20.3 thousand shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
PALLADIUM PARTNERS LLC Bought 200.00 shares of Novogen Ltd